Authors:
Axdorph, U
Porwit-MacDonald, A
Grimfors, G
Bjorkholm, M
Citation: U. Axdorph et al., Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease, LEUK LYMPH, 42(5), 2001, pp. 1055
Authors:
Lucio, P
Gaipa, G
van Lochem, EG
van Wering, ER
Porwit-MacDonald, A
Faria, T
Bjorklund, E
Biondi, A
van den Beemd, MWM
Baars, E
Vidriales, B
Parreira, A
van Dongen, JJM
San Miguel, JF
Orfao, A
Citation: P. Lucio et al., BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings, LEUKEMIA, 15(8), 2001, pp. 1185-1192
Authors:
Malec, M
Bjorklund, E
Soderhall, S
Mazur, J
Sjogren, AM
Pisa, P
Bjorkholm, M
Porwit-MacDonald, A
Citation: M. Malec et al., Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL, LEUKEMIA, 15(5), 2001, pp. 716-727
Authors:
MacNamara, B
Xu, DW
Wang, WH
Chen, ZG
Hou, M
Mazur, J
Gruber, A
Porwit-MacDonald, A
Citation: B. Macnamara et al., Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas, HAEMATOLOG, 86(4), 2001, pp. 386-393
Authors:
Axdorph, U
Sjoberg, J
Grimfors, G
Landgren, O
Porwit-MacDonald, A
Bjorkholm, M
Citation: U. Axdorph et al., Biological markers may add to prediction of outcome achieved by the international prognostic score in Hodgkin's disease, ANN ONCOL, 11(11), 2000, pp. 1405-1411
Authors:
Porwit-MacDonald, A
Bjorklund, E
Lucio, P
van Lochem, EG
Mazur, J
Parreira, A
van den Beemd, MWM
van Wering, ER
Baars, E
Gaipa, G
Biondi, A
Ciudad, J
van Dongen, JJM
San Miguel, JF
Orfao, A
Citation: A. Porwit-macdonald et al., BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7(+) cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL), LEUKEMIA, 14(5), 2000, pp. 816-825
Authors:
Knaust, E
Porwit-MacDonald, A
Gruber, A
Xu, DW
Peterson, C
Citation: E. Knaust et al., Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin, HAEMATOLOG, 85(2), 2000, pp. 124-132
Authors:
MacNamara, B
Palucka, KA
Porwit-MacDonald, A
Citation: B. Macnamara et al., Balance between proliferation and apoptosis in leukemic cell lines resistant to cytostatics, LEUK LYMPH, 36(1-2), 1999, pp. 179
Authors:
Palucka, KA
Knaust, E
Xu, DW
Macnamara, B
Porwit-MacDonald, A
Gruber, A
Peterson, C
Bjorkholm, M
Pisa, P
Citation: Ka. Palucka et al., Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemia, LEUK LYMPH, 32(3-4), 1999, pp. 309-316
Authors:
Lucio, P
Parreira, A
van den Beemd, MWM
van Lochem, EG
van Wering, ER
Baars, E
Porwit-MacDonald, A
Bjorklund, E
Gaipa, G
Biondi, A
Orfao, A
Janossy, G
van Dongen, JJM
San Miguel, JF
Citation: P. Lucio et al., Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL, LEUKEMIA, 13(3), 1999, pp. 419-427
Authors:
Axdorph, U
Porwit-MacDonald, A
Sjoberg, J
Grimfors, G
Ekman, M
Wang, W
Biberfeld, P
Bjorkholm, M
Citation: U. Axdorph et al., Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function, BR J CANC, 81(7), 1999, pp. 1182-1187